-
Mashup Score: 0ENGAGE Workshop - 7 month(s) ago
NHLBI presents the Enhancing Implementation of Guidelines and Evidence-based Care in Clinical and Community Settings (ENGAGE) Workshop
Source: www.eventbrite.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Pri-Med | Sarcoidosis in the Lungs: What... - 7 month(s) ago
Already listened on another platform? 0.25 AMA PRA Category 1 Credits ™, 0.25 ABIM MOC or 0.25 AANP, including 0.25 AANP Pharm The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Mridu Gulati, MD, MPH: Speaker for Boehringer Ingelheim. Advisor for CDC/NIOSH. Researcher for Boehringer Ingelheim and Bristol Myers Squibb. George A. Mensah, MD: No relevant financial relationships disclosed. Charles Vega, MD, FAAFP (Moderator):
Source: www.pri-med.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.#NHLBI curriculum. #PrimaryCare: Earn CME credit via @PriMedCME podcast presented with @StopSarcoidosis on what to know about #sarcoidosis in the #lungs. #ImpSci @NIH. Speakers: Dr. George Mensah at @NIH_NHLBI & Dr. Mridu Gulati at @YaleMed. Listen here: https://t.co/BA63h3IpbS https://t.co/yzJcy9mqTp
-
-
Mashup Score: 5
This interactive tool demonstrates data from the Global Burden of Cardiovascular Diseases and Risks Collaboration, 1990-2021, which reports the magnitude of total CVD burden, including by disease state and risk factors across 21 global regions. This tool demonstrates the data in three sections: Total CVD mortality rates by region Mortality rates by CV disease state Risk factors, location metrics & socioeconomic data Explore each of these interactive settings to delve into these important global data. Published by the Global Burden of CVD Collaboration—an alliance between JACC, the Institute for Health Metrics and Evaluation, and the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2022 Dec, 80 (25) 2372–2425.
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
Dr. Gregory Roth (@IHME) highlights the Global Burden of #CVD interactive resource on @JACCJournals at #ESCCongress. 🌎 Explore data rich visualization from across 21 regions here: https://t.co/OQTdPyZ9ac #GBDStudy #JACC #CardioTwitter https://t.co/3nHCI1MqAe
-
.#ESCCongress2023: Live now. Insightful JACC Joint session. Location: Hub Mondrian. #Global burden of #CVD & risks: what should #European cardiovascular clinicians do? Also check out the #GBDStudy interactive tool: #JACC #NHLBI #IHME. https://t.co/b8iSqaRBPY #ESCCongress #cvPrev https://t.co/f0maHOsS2P
-
-
Mashup Score: 0
NIH has awarded $24 million in first-year funding to establish Maternal Health Research Centers of Excellence. The centers will develop and evaluate innovative approaches to reduce pregnancy-related complications and deaths and promote maternal health equity.
Source: www.nichd.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet-
.@NICHD_NIH: New. @NIH has established #MaternalHealth Research Centers of Excellence. Read more about this new initiative to reduce #pregnancy-related complications & deaths and promote maternal health equity at https://t.co/iIq8TE3mAN. #ImpSci #NIH_IMPROVE #NICHD #NHLBI #ORWH https://t.co/kU8bmV8ykH
-
-
Mashup Score: 1Thin, soft, wearable system for continuous wireless monitoring of artery blood pressure - 8 month(s) ago
Nature Communications – Continuous monitoring of arterial blood pressure is limited by bulky connecting systems and poor interfacial contact. Here, Li et al. report a wearable thin, soft,…
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.@Nature: Jian Li at @CityUHongKong and colleagues share working principles & layout of a thin, soft, #wearable system for continuous wireless #monitoring of arterial #BloodPressure. #Innovative #hypertension #BiomedEngineering @NIBIBgov @NIH #NHLBI Read: https://t.co/WOTRHKLzma https://t.co/L29Ff0xsio
-
-
Mashup Score: 0Please wait whilst we redirect you - 9 month(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0GACD announces its 2022 Achievement Report | GCAD - 9 month(s) ago
We are pleased to announce the publication of the Global Alliance for Chronic Diseases Achievement Report, which provides an overview of our accomplishments and the strides we have taken in advancing the global fight against chronic non-communicable diseases (NCDs) in 2022. Through our growing worldwide investment in implementation research, we are building global knowledge on how best to tackle…
Source: gacd.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
At #NHLBI, we are proud to support research funded through the #Global Alliance for Chronic Diseases #GACD. It's really good to see the growing worldwide investment in #implementation research. #ImpSci Read: 2022 Achievement Report: https://t.co/WFmiTCgzt0 @GACD_media @NIH_NHLBI: https://t.co/SMTBXds8B5
-
-
Mashup Score: 0Evolution of the Pulse Ox - 10 month(s) ago
Section snippetsFunding/SupportThe authors were funded by the Intramural Research Program, National Institutes of Health/National Heart, Lung, and Blood Institute.Financial/Nonfinancial DisclosuresNone declared.AcknowledgmentsOther contributions: We thank Dr Robert S. Balaban for helpful discussions on the mechanisms of pulse oximeter discrepancies based on skin color.Role of sponsors: The…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.@NIH_NHLBI: New Funding Opportunity. Read the commentary in #CHEST by Bennett Yang & Joel Moss on the evolution of the pulse oximeter and the related new Small Business Innovation Research funding opportunity. #NHLBI #SBIR #NOFO #Technology #COVID #Oxygen https://t.co/e4EMC2Ybrx https://t.co/6J34p4Xy3A
-
-
Mashup Score: 1Intensive vs Standard Blood Pressure Control and Incident Left Ventricular Conduction Disease - 10 month(s) ago
This post hoc analysis of the SPRINT randomized clinical trial evaluates the association of intensive vs standard blood pressure control with incident left ventricular conduction disease.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.@NIH-funded: #SPRINT Trial: Compared with standard BP treatment, intensive BP control in persons with HTN was associated with a 26% lower risk of left heart conduction disease - suggesting that left heart arrhythmia may be preventable. #RCT #ImpSci #NHLBI https://t.co/mUBKsUHfRZ https://t.co/LQ1Wk9djiq
-
-
Mashup Score: 0Biomedicine Lecture Series and Health Equity Research Outreach (BLS-HERO) Joint Event - Contagious Information: Building Trust While Debunking Disinformation - 10 month(s) ago
The Center for Translation Research and Implementation Science (CTRIS) at the National Heart, Lung, and Blood Institute (NHLBI) invites you to join the second session in the 2023 Health Equity Research Outreach (HERO) Quarterly Lecture Series combined with Biomedicine Lecture Series (BLS). We are pleased to have as our speaker, Dr. Seema Yasmin, Director – Stanford Health Communication…
Source: NIH VideoCastingCategories: Hem/Oncs, Latest HeadlinesTweet
.@NIH: ENGAGE workshop, October 16-17, will explore factors in successful approaches for #guideline development, #implementation #dissemination and identification of priority areas! #ImpSci @ImplementSci #NHLBI #ENGAGE @Fogarty_NIH @Brian_Mittman @TCI_ca https://t.co/HBXUrKIMMC https://t.co/JGc4RTvHfR